Anne Stidsholt Roug

1.1k total citations
53 papers, 522 citations indexed

About

Anne Stidsholt Roug is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Anne Stidsholt Roug has authored 53 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 26 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Anne Stidsholt Roug's work include Acute Myeloid Leukemia Research (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers) and Acute Lymphoblastic Leukemia research (13 papers). Anne Stidsholt Roug is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers) and Acute Lymphoblastic Leukemia research (13 papers). Anne Stidsholt Roug collaborates with scholars based in Denmark, United Kingdom and United States. Anne Stidsholt Roug's co-authors include Peter Hokland, Line Nederby, Gordon D. Brown, Eigil Kjeldsen, Hans Beier Ommen, Tom Just, Charlotte Guldborg Nyvold, Tarec Christoffer El‐Galaly, Martin Bøgsted and Karen Dybkær and has published in prestigious journals such as Blood, PLoS ONE and European Journal of Cancer.

In The Last Decade

Anne Stidsholt Roug

50 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Stidsholt Roug Denmark 13 286 213 133 124 118 53 522
Swapna Thota United States 11 328 1.1× 269 1.3× 141 1.1× 91 0.7× 116 1.0× 55 621
Montserrat Torrebadell Spain 10 354 1.2× 224 1.1× 189 1.4× 144 1.2× 80 0.7× 21 571
Sumithira Vasu United States 16 355 1.2× 251 1.2× 82 0.6× 183 1.5× 316 2.7× 49 700
Gloria Cheang United States 3 310 1.1× 146 0.7× 155 1.2× 53 0.4× 47 0.4× 3 419
Bianca F. Goemans Netherlands 10 419 1.5× 200 0.9× 115 0.9× 85 0.7× 45 0.4× 34 563
V. Shetty United States 7 505 1.8× 250 1.2× 135 1.0× 57 0.5× 130 1.1× 9 643
Christine Vaupel United States 7 346 1.2× 111 0.5× 165 1.2× 125 1.0× 50 0.4× 19 473
Birgitte Preiss Denmark 12 461 1.6× 207 1.0× 156 1.2× 143 1.2× 39 0.3× 25 554
Ángel Ramírez Páyer Spain 12 177 0.6× 162 0.8× 172 1.3× 263 2.1× 286 2.4× 33 609
Sofia von Palffy Sweden 7 271 0.9× 137 0.6× 66 0.5× 94 0.8× 100 0.8× 11 440

Countries citing papers authored by Anne Stidsholt Roug

Since Specialization
Citations

This map shows the geographic impact of Anne Stidsholt Roug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Stidsholt Roug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Stidsholt Roug more than expected).

Fields of papers citing papers by Anne Stidsholt Roug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Stidsholt Roug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Stidsholt Roug. The network helps show where Anne Stidsholt Roug may publish in the future.

Co-authorship network of co-authors of Anne Stidsholt Roug

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Stidsholt Roug. A scholar is included among the top collaborators of Anne Stidsholt Roug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Stidsholt Roug. Anne Stidsholt Roug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen, Jonas, Joachim Bæch, Claus Werenberg Marcher, et al.. (2025). Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline‐containing chemotherapy: A population‐based matched cohort study. British Journal of Haematology. 207(4). 1416–1424.
2.
3.
Roug, Anne Stidsholt, Claus Werenberg Marcher, Andreas Due Ørskov, et al.. (2024). Outcomes among non‐Western immigrant patients and Danish‐born patients with acute myeloid Leukaemia: A Danish population‐based cohort study. British Journal of Haematology. 208(2). 564–569.
4.
Jakobsen, Lasse Hjort, et al.. (2024). Metformin use and risk of myeloproliferative neoplasms: a Danish population–based case-control study. Blood Advances. 8(16). 4478–4485. 3 indexed citations
5.
Brøndum, Rasmus Froberg, Andreas Due Ørskov, Claus Werenberg Marcher, et al.. (2023). Venetoclax‐based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy. European Journal Of Haematology. 111(4). 573–582. 3 indexed citations
6.
Naur, Therese Maria Henriette, Lasse Hjort Jakobsen, Anne Stidsholt Roug, et al.. (2021). Treatment intensity and survival trends among real-world elderly AML patients diagnosed in the period 2001–2016: a Danish nationwide cohort study. Leukemia & lymphoma. 62(8). 2014–2017. 2 indexed citations
7.
Schönherz, Anna A., Julie Støve Bødker, Alexander Schmitz, et al.. (2020). Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact. PLoS ONE. 15(4). e0229593–e0229593. 3 indexed citations
8.
Jakobsen, Lasse Hjort, Anne Stidsholt Roug, Claus Werenberg Marcher, et al.. (2020). Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study. British Journal of Haematology. 193(3). 482–487. 17 indexed citations
9.
Bødker, Julie Støve, Mads Sønderkær, Alexander Schmitz, et al.. (2020). Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark. Cancers. 12(2). 312–312. 8 indexed citations
10.
Aggerholm, Anni, Gitte Kerndrup, Marcus Høy Hansen, et al.. (2020). Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation. Blood Advances. 4(5). 885–892. 31 indexed citations
11.
Roug, Anne Stidsholt, et al.. (2017). The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia. Cytometry Part B Clinical Cytometry. 94(3). 520–526. 9 indexed citations
12.
Schönherz, Anna A., Julie Støve Bødker, Alexander Schmitz, et al.. (2016). Low Expression of Mir-155 in Vincristine Resistant Diffuse Large B-Cell Lymphoma. Haematologica. 101. 398–398. 1 indexed citations
13.
14.
Roug, Anne Stidsholt, Marcus Høy Hansen, Line Nederby, & Peter Hokland. (2014). Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age. British Journal of Haematology. 167(2). 162–176. 10 indexed citations
15.
Kjeldsen, Eigil, et al.. (2014). A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia. Leukemia Research Reports. 3(2). 94–97. 1 indexed citations
16.
Nederby, Line, Eigil Kjeldsen, Kirsten Grønbæk, et al.. (2013). Kinetics of del(7q) driven leukemogenesis in a patient with JAK2 V617F and TET2 mutated chronic myeloproliferative neoplasm. Leukemia Research Reports. 2(2). 51–53. 1 indexed citations
17.
Hokland, Peter, Hans Beier Ommen, Charlotte Guldborg Nyvold, & Anne Stidsholt Roug. (2012). Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission – methodologies in relation to their clinical situation. British Journal of Haematology. 158(5). 569–580. 23 indexed citations
18.
Petersen, Charlotte Christie, Line Nederby, Anne Stidsholt Roug, et al.. (2011). Increased Expression of CD69 on T Cells as an Early Immune Marker for Human Cytomegalovirus Reactivation in Chronic Lymphocytic Leukemia Patients. Viral Immunology. 24(2). 165–169. 4 indexed citations
19.
Roug, Anne Stidsholt, et al.. (2011). Expression of the hMICL in acute myeloid leukemia—a highly reliable disease marker at diagnosis and during follow‐up. Cytometry Part B Clinical Cytometry. 82B(1). 3–8. 46 indexed citations
20.
Roug, Anne Stidsholt, et al.. (2009). The CD94/NKG2C-Expressing NK Cell Subset Is Augmented in Chronic Lymphocytic Leukemia Patients with Positive Human Cytomegalovirus Serostatus. Viral Immunology. 22(5). 333–337. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swapna Thota Breakdown of academic impact, for papers by Montserrat Torrebadell Breakdown of academic impact, for papers by Sumithira Vasu Breakdown of academic impact, for papers by Gloria Cheang Breakdown of academic impact, for papers by Bianca F. Goemans Breakdown of academic impact, for papers by V. Shetty Breakdown of academic impact, for papers by Christine Vaupel Breakdown of academic impact, for papers by Birgitte Preiss Breakdown of academic impact, for papers by Ángel Ramírez Páyer Breakdown of academic impact, for papers by Sofia von Palffy
Rankless by CCL
2026